Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.58% advanced 1.46% to $159.38 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +1.51% falling 0.84% to 4,538.43 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.84% falling 0.17% to 34,580.08. Johnson & Johnson closed $20.54 below its 52-week high ($179.92), which the company reached on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF -1.51% rose 0.70% to $396.25, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -0.36% fell 0.74% to $73.34, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +1.03% rose 2.32% to $54.27. Trading volume (8.5 M) eclipsed its 50-day average volume of 7.1 M.